Details of the Drug

General Information of Drug (ID: DM3KCIP)

Drug Name

IMGN632

Indication

Disease Entry	ICD 11	Status	REF
Blastic plasmacytoid dendritic cell neoplasm	2A60.5	Phase 1/2	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT03386513) Study of IMGN632 in Patients With Untreated BPDCN and Relapsed/Refractory BPDCN. U.S. National Institutes of Health.